Market Overview

18 Biggest Mid-Day Losers For Tuesday

  • EnteroMedics Inc (NASDAQ: ETRM) shares dropped 24 percent to $4.64 after the company reported its earnings for the three-month period ending March 31, 2017, and an overview of its recent commercialization and corporate achievements. During the quarter, the company reported sales of $40,000 with gross profits totaling $11,000. Net loss for the quarter totaled $7.4 million while the company ended the period with cash, cash equivalents and short-term investments of $18.7 million.
  • Bovie Medical Corporation (NYSE: BVX) shares dipped 23.8 percent to $2.02. Bovie Medical reported a Q1 loss of $0.06 per share on sales of $8.4 million.
  • Mirna Therapeutics Inc (NASDAQ: MIRN) shares tumbled 20.2 percent to $1.62. Synlogic and Mirna Therapeutics agreed to merge in an all-stock deal.
  • Pernix Therapeutics Holdings Inc (NASDAQ: PTX) fell 18.2 percent to $4.69. Pernix Therapeutics reported a Q1 loss of $2.94 per share on revenue of $29.742 million.
  • ImmunoCellular Therapeutics Ltd (NYSE: IMUC) shares declined 16 percent to $1.31. ImmunoCellular Therapeutics reported a Q1 loss of $1.64 per share.
  • Xenetic Biosciences Inc (NASDAQ: XBIO) fell 15.6 percent to $2.70 as the company posted a wider-than-expected quarterly loss.
  • Virtusa Corporation (NASDAQ: VRTU) declined 14.8 percent to $27.61 on downbeat Q4 results.
  • VOXX International Corp (NASDAQ: VOXX) shares dipped 13.4 percent to $6.15 after the company posted weak quarterly results.
  • TearLab Corp (NASDAQ: TEAR) declined 11.5 percent to $2.30 after the company posted disappointing quarterly results.
  • Akers Biosciences Inc (NASDAQ: AKER) dropped 11.4 percent to $1.55. Akers Biosciences posted Q1 net loss attributable to shareholders of $1,349,270, and revenue $667,250.
  • Fate Therapeutics Inc (NASDAQ: FATE) shares fell 11.2 percent to $3.65 as the company posted a bigger-than-expected Q1 loss.
  • Dicks Sporting Goods Inc (NYSE: DKS) shares declined 10.8 percent to $42.47. Dicks posted in-line quarterly earnings but same-store sales missed estimates. UBS downgraded Dick's from Buy to Hold.
  • Viewray Inc (NASDAQ: VRAY) dropped 10 percent to $6.30. ViewRay reported a Q1 loss of $28 million on sales of $1.2 million.
  • Forterra Inc (NASDAQ: FRTA) tumbled 9.6 percent to $13.50. RBC Capital downgraded Forterra from Outperform to Sector Perform, while SunTrust Robinson Humphrey downgraded the stock from Buy to Hold.
  • Capricor Therapeutics Inc (NASDAQ: CAPR) fell 9.3 percent to $1.08 on wider-than-expected quarterly loss.
  • Staples, Inc. (NASDAQ: SPLS) declined 4.8 percent to $8.87. Staples posted upbeat profit for its first quarter, but sales missed expectations.
  • Stratasys, Ltd. (NASDAQ: SSYS) declined 3 percent to $29.04. Stratasys posted in-line quarterly earnings.
  • M.D.C. Holdings, Inc. (NYSE: MDC) fell 3 percent to $34.56. Wells Fargo downgraded M.D.C. from Market Perform to Underperform.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings


Related Articles (BVX + AKER)

View Comments and Join the Discussion!

Latest Ratings

ELMDDougherty & Co.Initiates Coverage On12.0
MRNSCantor FitzgeraldAssumes7.0
MNRLCapital One FinancialInitiates Coverage On23.0
SONVertical GroupUpgrades
UNPMorgan StanleyMaintains136.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

The President And The Russians: Are There Any Adults Capable Of 'Restraining Trump's Impulses?'

Chef's Warehouse, Performance Food Group: 2 Food Names Analysts Find Appetizing